GBTsol™ ICA is able to measure and analyze 3 fluorescence antibodies in oneshot, because this instrument is developed by convergence technology which comprises of BioTechnology,
Nano Technology, Optical Technology and Information Technology.
Use of samples from peripheral blood or infected subjects.
Qualitative measurement of disease marker with 5 μL of blood.
Fluorescence conjugated antibody labelling time: 10 min
Operation time: 5 min
The GBTsol™ ICA adapts new edge Nano-Filtration Technology. These Nano-Filters are characterized by pore size, density, spacing, and total area, depending on the origin and type of cells.
It also depends on which type of cells is selectively harvested.
GBTsol™ ICA contains an advanced
high-performance optical system that delivers precise and sensitive fluorescence detection, facilitating all 3 color multiplex applications.
A Cartridge containing Nano-Filter moves to the LED and camera, then LED light source passes through the Nano-Filter hole, and the cells that are seated in the hole receive energy.
At this time, the fluorescent antibody that was bound to the cell absorbs energy and emits light. This is the principle, which CMOS camera captures.
WBC recovery efficiency : ≥ 95% CV : ≤ 3%
CD4 helper and CD8 cytotoxic T lymphocyte count by the flow cytometer and leukocyte-counting device integrated with Nano-Filtration, illustrating the number of leukocytes for CD4, CD8 T Lymphocytes absolute counting.
Flow cytometric analysis was performed using BD Trucount Tubes and the absolute number of cells in 1 mL of whole blood was enumerated. The same blood sample was introduced into the leukocyte-counting device and each subset was enumerated. Results are represented as the mean (SD) of three independent measurements.
Examples of applications could include HIV immunity test, latent tuberculosis test, infertility and cancer diagnosis, hematopoietic stem cell transplantation test & Leukemia test.
■ Drug reaction test
■ Leukocyte cell study
■ Development of CAR-T cell therapy monitoring system
Unknown CD marker research will be used to identify the linkage to diseases using big data and to develop into an AI technology by deep learning.
GBTsol™ ICA is looking forward to expanding the application for Latent Tuberculosis and other immune cell-based diagnosis such as CD3 & CD34.
Type of CD markers that can be separated by GBTsol™ ICA are as follows:
CD1a, CD2, CD3, CD4, CD5, CD6, CD7, CD8, CD9, CD10, CD11a, CD11b, CD13, CD14, CD15, CD16, CD17, CD18, CD19, CD20, CD21, CD22, CD24, CD25, CD29, CD33, CD34, CD38, CD40, CD41, CD42b, CD43, CD44, CD45,
CD45RA, CD47, CD52, CD53, CD55, CD56, CD57, CD58, CD59, CD62E, CD62L, CD62P, CD64, CD71, CD99, CD99R, CD117, CD123, CD138, CD235a, CD235ab, CD319
Display 7" Touch Screen LCD Tablet PC (2G/32GB/with Win10 License)
Optical system LED excitation (340-750nm).
Power AC100V-240V, 50/60Hz
Dimensions (WxDxH) 265 X 245 X 362 mm
=> 제품 문의 : (주)글로리바이오텍 T. 02-6095-7858 / http://glorybt.com
=> 원하시는 분들중 선착순 5분께 demonstration해 드립니다.